Milan, July 18, 2024 – Neopharmed Gentili S.p.A., a leading Italian primary care branded pharmaceutical company, backed by Ardian and NB Renaissance together with the Del Bono family, announces that CEO Eric Falcand has decided to step down from his position for personal reasons.
Alessandro Del Bono, who led the company prior to Eric’s appointment and is the current Chairman of the Board, will continue leading the company until a new CEO is appointed by the Board of Directors.